Literature DB >> 21873168

Novel complementary peptides to target molecules.

Hidechika Okada1, Masaki Imai, Fumiko Ono, Alan Okada, Toyohiro Tada, Yuka Mizue, Keiji Terao, Noriko Okada.   

Abstract

We generated an evolutionary computer program that generates complementary peptide (C-pep) sequences, with the potential to interact with a target peptide, by comparing several physico-chemical parameters of each pair of the complementary peptides being analyzed. We generated C-peps to target several molecules. About 30% of synthesized C-peps interfered with the function of their targets. C5a stimulates generation of TNFα and other inflammatory cytokines. Inhibition of C5a should be effective against sepsis, which impairs the status of cancer-bearing patients. One of the inhibitory C-peps of C5a, termed AcPepA, was effective in Cynomolgus monkeys intravenously infused with a lethal dose of bacterial LPS (4 mg/kg) destined to die. The monkeys were rescued by intravenous administration of 2 mg/kg/h of AcPepA. The excellent therapeutic effect of AcPepA is likely to be due to restriction of high mobility group box 1 (HMGB1) surge induced by the effect of C5a on C5L2, which is the second C5a receptor, since the released HMGB1 has the capacity to stimulate TLR4 as an endogeneous ligand resulting in further activation of inflammatory cells to release inflammatory cytokines forming a positive feedback circuit of inflammation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873168

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Targeting the hedgehog signaling pathway with interacting peptides to Patched-1.

Authors:  Masafumi Nakamura; Haruo Tanaka; Yousuke Nagayoshi; Hiroshi Nakashima; Kosuke Tsutsumi; Takao Ohtsuka; Shunichi Takahata; Masao Tanaka; Hidechika Okada
Journal:  J Gastroenterol       Date:  2011-12-15       Impact factor: 7.527

2.  Treatment of Paraquat-Induced Lung Injury With an Anti-C5a Antibody: Potential Clinical Application.

Authors:  Shihui Sun; Yuting Jiang; Renxi Wang; Chenfeng Liu; Xiaoling Liu; Nianping Song; Yan Guo; Renfeng Guo; Lanying Du; Shibo Jiang; Yan Li; Zewu Qiu; Guangyu Zhao; Yusen Zhou
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

3.  Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in African green monkeys.

Authors:  Shihui Sun; Guangyu Zhao; Chenfeng Liu; Wei Fan; Xiaojun Zhou; Lin Zeng; Yan Guo; Zhihua Kou; Hong Yu; Junfeng Li; Renxi Wang; Yan Li; Conny Schneider; Maria Habel; Niels C Riedemann; Lanying Du; Shibo Jiang; Renfeng Guo; Yusen Zhou
Journal:  Clin Infect Dis       Date:  2014-11-27       Impact factor: 9.079

4.  Deficiency of C5L2 increases macrophage infiltration and alters adipose tissue function in mice.

Authors:  Danny Gauvreau; Abhishek Gupta; Alexandre Fisette; Fun-Qun Tom; Katherine Cianflone
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

5.  C5a inhibitor protects against ischemia/reperfusion injury in rat small intestine.

Authors:  Eszter Tuboly; Mitsuru Futakuchi; Gabriella Varga; Daniel Érces; Tünde Tőkés; Andras Mészáros; József Kaszaki; Masumi Suzui; Masaki Imai; Alan Okada; Noriko Okada; Mihály Boros; Hidechika Okada
Journal:  Microbiol Immunol       Date:  2016-01       Impact factor: 1.955

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.